Procurement of Nirsevimab for RSV Season 2025-2026
HUS GROUP THE JOINT AUTHORITY FOR HELSINKI AND UUSIMAA
The HUS Group is seeking suppliers for the procurement of Nirsevimab (Beyfortus 50 mg and 100 mg injection solution, pre-filled syringe) for use during the respiratory syncytial virus (RSV) epidemic season from October 1, 2025, to March 31, 2026. This medication is intended for infants under 3 month
AwardedHealthcare & MedicalFinlandPublished 26 Aug 2025
€10,500,000